A preclinical study by Zavorotinskaya et al., investigated the efficacy of rAAV carrying the interleukin 4 gene (IL-4) as a vector for gene therapy of allergic asthma, upon intratracheal delivery into the murine model [306]. The gene discussed is IL4; the disease is allergic asthma.